Insufficient pretransplant induction therapy is associated with diffuse intrahepatic cholangiopathy in ABO-incompatible living donor liver transplantation for acute liver failure
ABOi LDLT achieved outcomes comparable to those of ABOc LDLT among ESLD patients but not among ALF patients. DIC is associated with a high risk of allograft loss. However, the combination of potent immunosuppressive agents, early detection of antibody rebound, and timely initiation of salvage treatment may improve long-term outcomes in these patients.
Authors
- Fang-Cheng Kuo
- Chinsu Liu (ORCID: https://orcid.org/0000-0002-8768-8500)
- Cheng‐Yen Chen (ORCID: https://orcid.org/0000-0003-0258-2860)
- Yi-Fan Tsou (ORCID: https://orcid.org/0000-0001-7966-9388)
- Niang‐Cheng Lin (ORCID: https://orcid.org/0000-0002-2091-5625)
- Shen‐Chih Wang (ORCID: https://orcid.org/0000-0002-8732-1282)
- Chih-Yao Hu (ORCID: https://orcid.org/0000-0002-7294-716X)
- Pei-Chin Tsai
- Shu‐Cheng Chou (ORCID: https://orcid.org/0000-0001-6468-9837)
- Cheng‐Yuan Hsia (ORCID: https://orcid.org/0000-0002-2017-6359)
- Hsin‐Lin Tsai
- Hong Ngoc Cam Le
- Meng‐Hsuan Chung
- Che‐Chuan Loong
Institutions
- National Yang Ming Chiao Tung University (TW)
- Taipei Veterans General Hospital (TW)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1097/jcma.0000000000001211
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Taipei Veterans General Hospital